NYSE: JPM · JPMorgan Chase & Co.Enhanced Equity Research · May 31, 2026
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — JPMorgan Chase & Co. (JPM)
Fortress Balance SheetBest-in-Class ROTCEDurable Dividend Compounder

JPM

JPMorgan Chase & Co. — Enhanced Equity Research
Current Price
$299.31
Market Cap
823B
52-Week High
337.25
52-Week Low
260.31
BUY
PT $331
+11% upside · Med-High conviction

Fortress Bank, Durable Dividend, Premium-to-Peer Multiple

JPMorgan Chase (JPM) trades at $299.31, just off its 52-week high of $337, after another record quarter. Q1 2026 delivered net revenue of $49.8B (+10% YoY) and net income of $16.5B with diluted EPS of $5.94 (+17%), beating the $5.49 consensus by ~8%. The print featured record markets revenue of $11.6B, investment-banking fees +28%, NII +9%, and improving credit (provision down 24% to $2.5B). ROE/ROTCE of 19%/23% and a 14.3% CET1 ratio anchor a fortress balance sheet. For the dividend holder, the appeal is durability: a $6.00 annual dividend yields ~1.98% on a low ~29% payout, with 16 consecutive years of increases (a Dividend Achiever — not an Aristocrat, due to the 2009 crisis cut) and ~$8.1B of LTM net buybacks. Risk is valuation: at ~2.87x tangible book and ~13.7x forward EPS, JPM trades at a premium to peers, leaving modest price upside to a Street average near $331-345.

Q1 2026 Snapshot — Record markets revenue, net income +13% YoY, and a 23% ROTCE underscore the fortress balance sheet backing a durable, well-covered dividend.

Net Revenue (Q1'26)
$49.8B
+10% YoY · beat consensus
Diluted EPS (Q1'26)
$5.94
+17% YoY · beat $5.49 est.
ROTCE
23%
ROE 19% · best-in-class returns
Net Interest Income
+9%
FY26 NII guide ~$103B
Markets Revenue
$11.6B
Record · IB fees +28% YoY
Credit Provision
$2.5B
-24% YoY · NCOs stable $2.3B
CET1 Ratio
14.3%
$291B CET1 capital · fortress
Forward P/E
13.7x
P/TBV 2.87x · premium to peers

Quarterly Net Revenue Trend

$45.7B
Q2'25
$47.1B
Q3'25
$46.0B
Q4'25
$49.8B
Q1'26

A Well-Covered, Compounding Dividend Backed by Fortress Capital

$6.00
Annual Dividend / Share
~1.98% yield · ~29% payout ratio
16 yrs
Consecutive Dividend Hikes
Dividend Achiever · +7.1% latest raise
82%
Net Payout Ratio (LTM)
~$8.1B buybacks + dividends
Jul 2025
Dividend Raised ~7% to $1.50/qtr
Post-CCAR stress-test pass, JPM lifted the quarterly dividend to $1.50 ($6.00 annualized) and authorized a large new buyback — extending the increase streak to 16 years.
Jan 2026
Q4 2025: EPS $5.23 (ex-items)
Beat $4.86 consensus by ~7.6%; full-year 2025 record profits. Management projected ~$103B of NII for 2026 and adjusted expenses near $105B.
Apr 14, 2026
Q1 2026: Record Quarter
Net revenue $49.8B (+10%), net income $16.5B, EPS $5.94 (+17%), record markets revenue $11.6B, IB fees +28%, ROTCE 23%, CET1 14.3%.
May 2026
Dimon Flags 'Complex Risks'
Despite record results, CEO Jamie Dimon cautioned on geopolitics, sticky inflation and credit normalization — a measured tone underpinning JPM's conservative reserving.
Jul 2026
Next Dividend & CCAR Catalyst
Ex-date ~Jul 3 / pay date ~Jul 31 at $1.50. The 2026 stress-test results are the next gate for a 17th consecutive annual increase and fresh buyback capacity.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus~$21.90 (FY2026e)
FY+2 EPS Consensus~$22.80 (FY2027e)
PEG Ration/a (cyclical bank)
Forward P/E13.7x
EPS Revisions (90d)↑11 ↓4 (Net upward — estimates revised higher after the Q1'26 beat and record markets/IB results, tempered by valuation caution.)
Guidance AccuracyStrong — NII and expense guidance (FY26 NII ~$103B, adj. expenses ~$105B) historically conservative and reliably met or exceeded.

Earnings Surprise Track Record

Q2'25 Est: $4.48 Act: $4.96 +10.7%
Q3'25 Est: $4.84 Act: $5.07 +4.7%
Q4'25 Est: $4.86 Act: $5.23 +7.6%
Q1'26 Est: $5.49 Act: $5.94 +8.2%
Beat RateBeat EPS in 4 of last 4 quarters

Insider Activity (90 Days)

Net Buying/SellingNet neutral
Sell/Buy RatioRoutine disposition only
Neutral
No material discretionary insider buying or selling in the trailing 90 days beyond routine compensation-related dispositions and option-related activity. Insider signal is neutral; the investment case rests on fundamentals and capital returns, not insider conviction.

Relative Valuation vs. Competitors

CompanyFwd P/EP/TBVROTCEDiv Yield
JPMorgan13.7x2.87x23%1.98%
Bank of America12.0x1.6x~14%2.1%
Wells Fargo12.5x1.9x~15%2.3%
Citigroup10.5x0.9x~9%2.6%
JPM commands the highest P/TBV (~2.87x vs 0.9-1.9x for peers) and the richest ROTCE (~23% vs 9-15%), reflecting a genuine quality premium. The trade-off is the lowest dividend yield (~1.98%) and the least valuation cushion: BAC, WFC and especially C offer cheaper TBV multiples and higher yields, but none match JPM's returns, scale or capital strength. The premium is earned, yet it caps near-term price upside.

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
Bull Case$400NII tops ~$103B guide as deposits reprice favorably; capital-markets boom sustains record markets/IB fees; credit stays benign; buybacks accelerate and the multiple re-rates toward 3.5x TBV on best-in-class ~23% ROTCE.25%
Base Case$330Mid-single-digit revenue growth, NII near the ~$103B guide, ROTCE held ~18-20%, steady ~7-8% annual dividend hikes and ongoing buybacks; multiple holds near ~13-14x forward / ~2.8x TBV.50%
Bear Case$250Recession-driven credit normalization lifts provisions, NII compresses as rates fall and deposits reprice, capital-markets revenue mean-reverts, and the premium TBV multiple de-rates toward the ~2.0x historical median.25%

Probability-Weighted Target: $332 (+11% from current price)

$332
Weighted
Bull $40025%
Base $33050%
Bear $25025%

Analyst Consensus

Consensus Median
$345
Buy / 31 analysts
Consensus Average
$331
Buy / Maintained
Street Low
$289
Hold / Cautious
Street High
$400
Buy / Bullish
Buy consensus across ~31 analysts (15 buy, 3 strong buy, 13 hold, 0 sell). Median 12-month target ~$345 and average ~$331 imply roughly +11% to +15% upside from $299.31, with a range of $289-$400. No Sell ratings on the panel.

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High
$337.25
Resistance
$308.29
200-Day MA
$305.65
Support
$305.20
50-Day MA
$302.12
Current Price
$299.31
52-Week Low
$260.31

OptOptions & Sentiment

  • Implied Volatility (30D): ~22% (moderate)
  • IV Percentile: ~40% (mid-range)
  • Put/Call Ratio (OI): 0.95 · balanced
  • Short Interest: ~0.9% float (low)
  • Days to Cover: ~1.5 days
  • Max Pain (near-term): ~$300
  • 30D IV Skew: Mild put-skew (hedging)
  • Trend vs 200-DMA: Just below ($305.65)

Systematic Conviction Score: 74/100 (Med-High)

75
Analyst Alignment
30%
85
FCF Visibility
25%
60
Catalyst Clarity
20%
55
Valuation Safety
15%
95
Mgmt Quality
10%
Best-in-class management and a fortress balance sheet (95 mgmt, strong earnings visibility) support a durable, well-covered dividend. Buy consensus with no sells. Tempered by a premium ~2.87x TBV / ~13.7x forward multiple (lower valuation safety) and the cyclical nature of bank catalysts (CCAR, rates, credit).

Risk Assessment & Insider Signals

!Risk Factors

  • Premium valuation vs. peers caps upside: At ~2.87x tangible book (44% above its 10-yr median of ~2.0x) and ~13.7x forward EPS, JPM is priced for continued excellence; any earnings wobble or sector de-rating compresses the multiple toward peers.
  • Credit normalization / recession: Provisions improved (-24% to $2.5B) but Dimon repeatedly flags 'complex risks.' A downturn that lifts charge-offs and reserve builds would hit EPS and slow buyback capacity even with strong reserves.
  • Net interest income compression: FY26 NII is guided to ~$103B; faster-than-expected Fed cuts and deposit repricing/competition could pressure NII below guidance, removing a key earnings pillar.
  • Capital-markets revenue mean-reversion: Record Q1'26 markets ($11.6B) and IB fees (+28%) reflect a strong cycle; trading and banking are inherently volatile and a slowdown would de-rate the recent earnings beat trajectory.
  • Regulatory & capital rules (Basel endgame): Evolving capital requirements and stress-test outcomes (CCAR) gate dividend growth and buybacks; a more punitive framework would slow shareholder returns despite the 14.3% CET1 buffer.
  • Low yield vs. dividend-peer alternatives: At ~1.98%, JPM's yield trails WFC (~2.3%), BAC (~2.1%) and C (~2.6%); income-focused capital could rotate to cheaper, higher-yielding banks if JPM's growth premium narrows.

OOwnership & Insider Signals

  • Institutional ownership ~74%: Roughly 74.4% of ~2.9B shares held by institutions — a deep, blue-chip holder base providing liquidity and stability for a core dividend position.
  • Top holders — index giants: Vanguard (~270.7M sh, 9.84%, ~$78.6B), BlackRock (~132.6M sh, 4.82%, ~$38.5B) and State Street (~125.3M sh, 4.56%) together hold close to 20%, anchoring JPM in index funds.
  • Broad active and sovereign holders: Other large holders include Geode, FMR/Fidelity, Norges Bank, Northern Trust, Morgan Stanley and T. Rowe Price — a mix of passive index and active institutional capital.
  • No controlling shareholder: Unlike founder-controlled names, JPM has a diffuse ownership base with standard one-share-one-vote governance, leaving board accountability to a broad shareholder body.
  • Low insider ownership: Aggregate insider ownership is modest (well under 1% of shares); CEO Jamie Dimon's stake is meaningful in dollars but small relative to the ~$823B market cap.
  • Index-anchored float: With ~74% institutional and heavy index ownership, effective tradable float concentrates among large funds, supporting deep liquidity but tying the stock to broad-market and financial-sector flows.

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Premium valuation vs. peers caps upside 45% -15%
Medium Credit normalization / recession 35% -18%
Medium Net interest income compression 35% -10%
Medium Capital-markets revenue mean-reversion 40% -8%
Low Regulatory & capital rules (Basel endgame) 25% -6%
Low Low yield vs. dividend-peer alternatives 30% -4%

Summary

Rating
BUY
Conviction
Med-High
Price Target
$331
Timeframe
12 mo
Upside
+11%
Position Size
4%-6%

Entry Strategy

1
Tranche 1 — 40%
~$299
Initiate near current levels just below the 50/200-DMA cluster; collect the ~1.98% yield while holding a Buy-rated, fortress-balance-sheet compounder.
2
Tranche 2 — 35%
~$280
Add on a pullback toward the mid-range of the 52-week band, improving yield-on-cost and valuation entry.
3
Tranche 3 — 25%
~$262
Reserve for a flush toward the 52-week low (~$260) — a high-quality re-rating opportunity in a sector-wide selloff.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of May 31, 2026.